AIRS
AirSculpt Technologies, Inc. · Healthcare · Medical Care Facilities
Last
$1.58
−$0.16 (−9.25%) 4:00 PM ET
Prev close $1.74
Open $1.76
Day high $1.76
Day low $1.57
Volume 402,097
Avg vol 1,144,975
Mkt cap
$98.65M
P/E ratio
-5.44
FY Revenue
$157.55M
EPS
-0.29
Gross Margin
58.90%
Sector
Healthcare
AI report sections
AIRS
AirSculpt Technologies, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−21% (Below avg)
Vol/Avg: 0.79×
RSI
37.10 (Weak)
Weak (30–40)
MACD momentum
Intraday
-0.00 (Weak)
MACD: -0.01 Signal: -0.01
Short-Term
-0.03 (Weak)
MACD: -0.21 Signal: -0.18
Long-Term
-0.04 (Weak)
MACD: -0.30 Signal: -0.26
Intraday trend score 20.00

Latest news

AIRS 12 articles Positive: 2 Neutral: 3 Negative: 1
Positive GlobeNewswire Inc. • Yogi Jashnani
AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board

AirSculpt Technologies appointed Mike Doyle as Non-Executive Chairman of its Board of Directors. Doyle brings over 30 years of leadership experience in multi-center healthcare and has previously led Surgery Partners and founded MD Healthcare Partners.

AIRS SGRY healthcare body contouring board appointment leadership
Sentiment note

Company is expanding leadership with an experienced executive, signaling strategic growth and potential organizational development

Neutral GlobeNewswire Inc. • Airsculpt Technologies, Inc.
AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results

AirSculpt Technologies reported Q2 2025 financial results with declining case volume and revenue, but narrowed year-over-year revenue decline and reduced net loss. The company is piloting new offerings and remains confident in its growth strategy.

AIRS body contouring medical procedures financial results revenue decline GLP-1 treatments
Sentiment note

Mixed financial performance with revenue and case volume decline, but reduced net loss, strategic initiatives, and management's optimistic outlook suggest potential for future improvement

Positive GlobeNewswire Inc. • N/A
AirSculpt Strengthens Balance Sheet with $10.0 Million Debt Paydown

AirSculpt Technologies, Inc. announced the voluntary prepayment of $10 million of its outstanding term loan debt using cash on hand, following the successful completion of its offering of 3,634,000 shares of common stock, which generated net proceeds of approximately $13.8 million.

AIRS AirSculpt common stock offering debt prepayment
Sentiment note

The company successfully completed a common stock offering, generating net proceeds of $13.8 million, and used a portion of the proceeds to prepay $10 million of its outstanding debt, which improves its capital structure and financial flexibility.

Neutral GlobeNewswire Inc. • N/A
AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance

AirSculpt Technologies, a provider of body contouring procedures, reported its Q1 2025 results. The company saw a decline in case volume and revenue compared to the prior year, leading to a net loss. However, the company expects sequential improvement in revenue as it focuses on increasing lead generation and consultations.

AIRS AirSculpt Technologies body contouring Q1 2025 earnings
Sentiment note

The company reported a decline in key metrics like case volume and revenue, leading to a net loss. However, the company expects to see sequential improvement in revenue going forward, indicating a neutral sentiment.

Negative GlobeNewswire Inc. • N/A
AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results

AirSculpt Technologies, a provider of body contouring procedures, reported a decline in revenue and case volume for the fourth quarter and full year 2024. The company is focused on stabilizing same-center sales performance and implementing cost reduction measures.

AIRS AirSculpt Technologies body contouring revenue decline cost reduction
Sentiment note

The article reports a decline in revenue and case volume for AirSculpt Technologies, indicating a challenging year for the company. However, the company is taking measures to stabilize its performance and improve profitability.

Neutral GlobeNewswire Inc. • N/A
AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results

AirSculpt Technologies, a provider of body contouring procedures, reported a decline in revenue and Adjusted EBITDA for Q3 2024 compared to the prior year. The company is focused on improving conversion of leads to cases and cost reduction efforts to return to positive revenue growth and improve margins.

AIRS AirSculpt Technologies body contouring revenue Adjusted EBITDA
Sentiment note

The company reported a decline in revenue and Adjusted EBITDA, but is taking steps to improve performance, indicating a neutral sentiment.

Unknown Zacks Investment Research • Zacks Equity Research
Do Options Traders Know Something About AirSculpt (AIRS) Stock We Don't?

Investors need to pay close attention to AirSculpt (AIRS) stock based on the movements in the options market lately.

AIRS
Unknown Zacks Investment Research • Zacks Equity Research
Here's Why AirSculpt Technologies (AIRS) Could be Great Choice for a Bottom Fisher

AirSculpt Technologies (AIRS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

AIRS
Unknown Zacks Investment Research • Zacks Equity Research
Down -38.41% in 4 Weeks, Here's Why AirSculpt Technologies (AIRS) Looks Ripe for a Turnaround

AirSculpt Technologies (AIRS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

AIRS
Unknown Zacks Investment Research • Zacks Equity Research
Compared to Estimates, AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Key Metrics

The headline numbers for AirSculpt Technologies (AIRS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

AIRS
Unknown Zacks Investment Research • Zacks Equity Research
AirSculpt Technologies, Inc. (AIRS) Lags Q1 Earnings and Revenue Estimates

AirSculpt Technologies (AIRS) delivered earnings and revenue surprises of -62.50% and 4.88%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

AIRS BITF
Unknown GlobeNewswire Inc. • Airsculpt Technologies, Inc.
AirSculpt Technologies Reports for First Quarter Earnings

MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2024.

AIRS Earnings Releases and Operating Results
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal